Five Questions

  • Progress toward precision health

    A perspective piece from Stanford scientists provides an overview of the value of precision health, its progress, challenges and how it can improve health at the individual and population level.


  • Ioannidis on antidepressant efficacy

    In a highly comprehensive meta-analysis of more than 500 clinical trials, researchers from around the world have drawn conclusions about the efficacy of 21 different antidepressants.


  • Q&A with Team USA physician

    A native of South Korea, the sports medicine specialist will be traveling to his home country for the Winter Olympics, where he’ll be on call to treat American athletes.


  • Mello on clinical trial reporting

    A Stanford professor of law and of health policy discusses the ranking of large pharmaceutical companies based on their sharing of clinical trial information with the public.


  • Stafford on high blood pressure

    Under the new guidelines, tens of millions more Americans now meet the criteria for having high blood pressure.


  • New guidelines for PANS/PANDAS

    Stanford clinicians helped develop the first clinical guidelines for treating pediatric acute-onset neuropsychiatric syndrome, a psychiatric problem linked to brain inflammation.


  • Stefanick on better medicine for women

    A Stanford professor of medicine discusses why giving consideration to sex and gender differences in research and treatment would improve medical care for everyone.


  • Kelly Ormond on germline editing

    A Stanford professor of genetics discusses the thinking behind a formal policy statement endorsing the idea that researchers continue editing genes in human germ cells.


  • Samuel So on ending viral hepatitis

    A Stanford liver disease expert and leading anti-hepatitis campaigner recently discussed what it will take to rub out viral hepatitis and why it’s important. Hint: It causes more than 20,000 U.S. deaths annually.


  • Almond discusses trial of kids’ heart pump

    Stanford is leading a multisite study of a new ventricular assist device for children who are awaiting heart transplantation. The miniature pump is slightly bigger than a paper clip.



Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.